Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2024-12-16 | Amended | $7,429,000 | $3,032,000 | Debt Only | 06b | SEC link |
2023-10-31 | New | $4,397,000 | $4,397,000 | Debt Only | 06b | SEC link |
2021-10-29 | New | $5,039,710 | $5,039,710 | Equity Only | 06b | SEC link |
2019-10-28 | New | $915,667 | $915,667 | Equity Only | 06b | SEC link |
2018-07-12 | New | $900,000 | $900,000 | Equity and Debt | 06b | SEC link |
Name | Role |
---|---|
Sundaresh Brahmasandra | Director |
Gilbert G Garcia | Director |
Michael Partsch | Director |
Lauren Tyra | Director, Executive |
Steven Weinstein | Director |
Tobias Zutz | Director, Executive |